J. E. Davis, CEO and President, sold 10,000 shares of Quest Diagnostics Incorporated (NYSE:DGX) at $242.72 per share on Sept. 1, 2026, as disclosed in a recent SEC Form 4 filing.
Transaction summary
Transaction value based on SEC Form 4 weighted average sale price ($242.72); post-transaction value based on Sept. 1, 2026, market close ($236.22).
Key questions
What was the regulatory context of this transaction?
The sale was executed pursuant to a Rule 10b5-1 trading plan previously adopted by J. E. Davis, which allows insiders to schedule stock trades in advance to meet liquidity needs while complying with insider trading regulations.How does this sale impact the executive’s total equity position?
Following the disposal of 10,000 shares, J. E. Davis continues to hold a direct position of 122,423 shares in the diagnostic testing company, which represents a total post-transaction value of $28.9 million as of the Sept. 1, 2026, market close.What has been the recent performance context for the stock?
The transaction took place at $242.72 per share, with the company’s equity having realized a 32% total return over the 12 months ending on the transaction date of Sept. 1, 2026.What is the broader ownership structure following this move?
Insiders collectively maintain a 0.11% ownership stake in the $26.4 billion firm, which provides advanced clinical and anatomic pathology testing services from its headquarters in Secaucus.
Company Overview
Company Snapshot
Quest Diagnostics provides comprehensive diagnostic testing services, including routine clinical testing, advanced diagnostic services, and anatomic pathology testing, generating revenue through laboratory testing fees and information services delivered to healthcare providers, employers, and patients.
The company operates a network-based business model that leverages its extensive laboratory infrastructure and patient service centers to deliver diagnostic information services at scale, with revenue generated from per-test fees, reference laboratory services, and data analytics offerings.
Quest Diagnostics serves a diverse customer base, including physicians, hospitals, employers, insurance companies, and individual patients, positioning itself as a critical intermediary in the healthcare value chain for diagnostic information and clinical decision support.
